Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Major Adverse Cardiovascular Outcomes in Families With MASLD: A Population-Based Multigenerational Cohort Study.

Circulation. Cardiovascular quality and outcomes - 1 Nov 2024

Ebrahimi Fahim, Ebrahimi Ramin, Hagström Hannes, Sundström Johan, Sun Jiangwei, Bergman David, Forss Anders, Ludvigsson Jonas F

Abstract excerpt

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a risk factor for cardiovascular disease. However, whether family members of individuals with MASLD also share an increased cardiovascular risk is unknown. METHODS: We created a nationwide multigenerational cohort study identifying all family members of Swedish adults diagnosed with biopsy-proven MASLD (1969-2017) and of matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Heart Disease Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heredity

Share to Incidence

Share to Non-alcoholic Fatty Liver Disease

Share to Registries

Share to Risk Assessment

Share to Sweden

Source

Identifiers

PMID: 39503614
DOI: 10.1161/CIRCOUTCOMES.124.010912

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Major Adverse Cardiovascular Outcomes in Families With MASLD: A Population-Based Multigenerational Cohort Study.PMID 39503614Read ↗

Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD.Semantic proximity Read ↗

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.Semantic proximity Read ↗

Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD.Semantic proximity Read ↗

Genome-wide insights into the shared genetic landscape between metabolic dysfunction-associated fatty liver disease and cardiovascular diseasesSemantic proximity Read ↗

Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals.Semantic proximity Read ↗

Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease.Semantic proximity Read ↗

Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read ↗

Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden.Semantic proximity Read ↗

Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.Semantic proximity Read ↗

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in population with MASLDSemantic proximity Read ↗

Causal association and genetic correlation of frailty with metabolic dysfunction-associated steatotic liver disease: Epidemiological and genetic analysesSemantic proximity Read ↗

Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.